Uncategorized
NovaBay Pharmaceuticals Provides Update on Avenova Sales Growth, Reports Progress with intelli-Case Test Market Launch and Product Pipeline Advancement
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals announces that third quarter sales of the company’s prescription daily lid and lash hygiene product Avenova™ are expected to reach more than $1 million.
